American Healthcare REIT, Inc. (AHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350M 700M 1.1B Q1 '16: 0 Q2 '16: 3K Q3 '16: 214K Q4 '16: 2.9M Q1 '17: 2.9M Q2 '17: 4.6M Q3 '17: 8.5M Q4 '17: 14.6M Q1 '18: 17.8M Q2 '18: 19M Q3 '18: 22.3M Q4 '18: 25.3M Q1 '19: 25.8M Q2 '19: 30.4M Q3 '19: 31.1M Q4 '19: 33.4M Q1 '20: 37.5M Q2 '20: 38.7M Q3 '20: 18.9M Q4 '20: 1B Q1 '21: 37.8M Q2 '21: 37.2M Q3 '21: 37.2M Q4 '21: 307.7M Q1 '22: 319M Q2 '22: 326.2M Q3 '22: 368.3M Q4 '22: 398.7M Q1 '23: 452.2M Q2 '23: 410.6M Q3 '23: 416.2M Q4 '23: 433.3M Q1 '24: 499.5M Q2 '24: 504.6M Q3 '24: 523.8M Q4 '24: 542.7M Q1 '25: 540.6M Q2 '25: 542.5M Q3 '25: 572.9M Q4 '25: 604.1M Q1 '26: 650.8M Q2 '26: 674.2M Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-50M 0 50M 100M 150M Q3 '15: 0 Q4 '15: 0 Q1 '16: -150K Q2 '16: -613K Q3 '16: -2M Q4 '16: -2.2M Q1 '17: 333K Q2 '17: 1M Q1 '21: 38.1M Q2 '21: 49.5M Q3 '21: 52.5M Q4 '21: 73.2M Q1 '22: 73.7M Q2 '22: 77.6M Q3 '22: 73.8M Q4 '22: 76.9M Q1 '23: 66.9M Q2 '23: 80.4M Q3 '23: 75.1M Q4 '23: 84.5M Q1 '24: 82.2M Q2 '24: 88.7M Q3 '24: 93.5M Q4 '24: 99.1M Q1 '25: 94.5M Q2 '25: 103.2M Q3 '25: 105.8M Q4 '25: 111.6M Q1 '26: 125.5M Q2 '26: 137.2M Q4 '15 Q4 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: -150K Q2 '16: -613K Q3 '16: -2.1M Q4 '16: -2.6M Q1 '17: -85K Q2 '17: 621K Q3 '17: 754K Q4 '17: -749K Q1 '18: -2.2M Q2 '18: -900K Q3 '18: -1.6M Q4 '18: -3.7M Q1 '19: -12.3M Q2 '19: -5.9M Q3 '19: -1.9M Q4 '19: 1.3M Q1 '20: -7.8M Q2 '20: -946K Q3 '20: -4.9M Q4 '20: 15.8M Q1 '21: -11.8M Q2 '21: -7.7M Q3 '21: -5.2M Q4 '21: -23M Q1 '22: -3M Q2 '22: -17.3M Q3 '22: -13.5M Q4 '22: -47.5M Q1 '23: -25.9M Q2 '23: -12.2M Q3 '23: -6M Q4 '23: -27.4M Q1 '24: -3.9M Q2 '24: 2M Q3 '24: -4.1M Q4 '24: -31.8M Q1 '25: -6.8M Q2 '25: 9.9M Q3 '25: 55.9M Q4 '25: 10.8M Q1 '26: 23.7M Q2 '26: 30.6M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue Quarterly

0 350M 700M 1.1B Q3 '17: 0 Q4 '17: 4.2M Q1 '18: 7.2M Q2 '18: 6.8M Q3 '18: 8M Q4 '18: 8M Q1 '19: 8.5M Q2 '19: 9.8M Q3 '19: 9.9M Q4 '19: 939.7M Q1 '20: 13M Q2 '20: 14.4M Q3 '20: 17.4M Q4 '20: 948.9M Q1 '21: 245.1M Q2 '21: 250.4M Q3 '21: 256.8M Q4 '21: 277.8M Q1 '22: 287.2M Q2 '22: 296.1M Q3 '22: 337.5M Q4 '22: 360.8M Q1 '23: 370.1M Q2 '23: 372.5M Q3 '23: 374.6M Q4 '23: 385M Q1 '24: 403.6M Q2 '24: 402.6M Q3 '24: 417.1M Q4 '24: 430.6M Q1 '25: 432.4M Q2 '25: 426.3M Q3 '25: 454.5M Q4 '25: 480.3M Q1 '26: 512.2M Q2 '26: 524.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-70M 0 70M 140M 210M Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: -709K Q3 '16: -1.7M Q4 '16: -1.2M Q1 '17: 1.4M Q2 '17: 3.6M Q3 '17: 3.9M Q4 '17: 3.6M Q1 '18: 4.7M Q2 '18: 5M Q3 '18: 6M Q4 '18: -254K Q1 '19: 6.2M Q2 '19: 10.9M Q3 '19: 13.3M Q4 '19: 87M Q1 '20: 9.8M Q2 '20: 9.3M Q3 '20: 10.9M Q4 '20: 189.2M Q1 '21: -5.3M Q2 '21: 8.8M Q3 '21: -5.1M Q4 '21: 19.4M Q1 '22: 22.4M Q2 '22: 33.8M Q3 '22: 57.3M Q4 '22: 34.3M Q1 '23: 23.9M Q2 '23: 19.8M Q3 '23: 29.1M Q4 '23: 25.8M Q1 '24: -6M Q2 '24: 59.4M Q3 '24: 63.1M Q4 '24: 59.5M Q1 '25: 60.6M Q2 '25: 71.5M Q3 '25: 107.2M Q4 '25: 55.2M Q1 '26: 81.1M Q2 '26: 118.6M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow Quarterly

-70M 0 70M 140M 210M Q1 '19: 4.6M Q2 '19: 10.3M Q3 '19: 11.2M Q4 '19: 84.9M Q1 '20: 7M Q2 '20: 7.4M Q3 '20: 8.8M Q4 '20: 187.6M Q1 '21: -6.3M Q2 '21: 7.6M Q3 '21: -7.1M Q1 '19 Q3 '19 Q1 '20 Q3 '20 Q1 '21 Q3 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '21: 179.6M Q2 '21: 179.6M Q3 '21: 179.6M Q1 '22: 65.6M Q2 '22: 65.8M Q3 '22: 65.8M Q1 '23: 66M Q2 '23: 66M Q3 '23: 66M Q1 '24: 104.3M Q2 '24: 130.7M Q3 '24: 133.7M Q1 '25: 156.9M Q2 '25: 161.1M Q3 '25: 169.8M Q1 '26: 188M Q2 '26: 193.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q1 '16: -7.20 Q2 '16: -8.16 Q3 '16: -8.78 Q4 '16: -9.09 Q1 '17: -1.90 Q2 '17: -0.91 Q3 '17: -0.27 Q4 '17: 0.02 Q1 '18: -0.02 Q2 '18: -0.07 Q3 '18: -0.12 Q4 '18: -0.16 Q1 '19: -0.27 Q2 '19: -0.32 Q3 '19: -0.31 Q4 '19: -0.23 Q1 '20: -0.17 Q2 '20: -0.11 Q3 '20: -0.15 Q4 '20: -0.22 Q1 '21: -0.19 Q2 '21: -0.22 Q3 '21: -0.19 Q4 '21: -0.95 Q1 '22: -0.93 Q2 '22: -1.15 Q3 '22: -1.33 Q4 '22: -1.25 Q1 '23: -1.59 Q2 '23: -1.52 Q3 '23: -1.40 Q4 '23: -1.08 Q1 '24: -0.73 Q2 '24: -0.53 Q3 '24: -0.47 Q4 '24: -0.30 Q1 '25: -0.30 Q2 '25: -0.25 Q3 '25: 0.11 Q4 '25: 0.41 Q1 '26: 0.58 Q2 '26: 0.68 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.